March 11, 2015 10:04 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NYSE: GY) shares gained 1.37% to reach a new 52-week high of $20.79. GenCorp's trailing-twelve-month revenue is $1.60 billion.
Synergetics USA, Inc. (NASDAQ: SURG) shares climbed 14.56% to touch a new 52-week high of $5.35. Synergetics USA reported better-than-expected Q2 earnings.
Inogen, Inc. (NASDAQ: INGN) shares gained 4.91% to reach a new 52-week high of $35.58. Inogen is expected to announce Q4 results on Thursday, March 12, 2015. Stifel Nicolaus upgraded Inogen from Hold to Buy.
Lion Biotechnologies, Inc. (NASDAQ: LBIO) shares rose 4.69% to touch a new 52-week high of $10.72. Lion Biotechnologies shares have jumped 23.52% over the past 52 weeks, while the S&P 500 index has gained 9.42% in the same period.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.